Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran.

Ali AbutorabiMarjan Haj AhmadiSaeed Bagheri FaradonbehAsma Rashki KemmakVahid Alipour

Published in: Medical journal of the Islamic Republic of Iran (2023)

Rivaroxaban, an oral medication, reduced costs and increased the quality of life in people undergoing knee replacement surgery compared with an enoxaparin injection vial. This drug was less costly for the patient and health systems and its use was cost-effective as a thromboprophylaxis drug following knee replacement surgery.

Keyphrases

venous thromboembolism
minimally invasive
direct oral anticoagulants
coronary artery bypass
total knee arthroplasty
knee osteoarthritis
surgical site infection
adverse drug
anterior cruciate ligament
anterior cruciate ligament reconstruction
emergency department
case report
ultrasound guided
drug induced